HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R Kauppinen Selected Research

R Kauppinen Research Topics

Disease

2Metabolic Diseases (Metabolic Disease)
02/2009 - 11/2000
2Acute Intermittent Porphyria (Porphyria, Acute)
02/2009 - 08/2000
2Lymphedema (Milroy Disease)
10/2001 - 02/2001
2Variegate Porphyria (Protoporphyrinogen Oxidase Deficiency)
05/2001 - 11/2000
1Neurologic Manifestations (Neurological Manifestations)
02/2009
1Infections
04/2001
1Reperfusion Injury
11/2000
1Infarction (Infarctions)
11/2000
1Erythropoietic Protoporphyria
09/2000
1Asthma (Bronchial Asthma)
01/2000

Drug/Important Bio-Agent (IBA)

4Heme (Haem)IBA
02/2009 - 08/2000
2Hydroxymethylbilane Synthase (Porphobilinogen Deaminase)IBA
02/2009 - 08/2000
2Vascular Endothelial Growth Factor CIBA
10/2001 - 02/2001
2Protoporphyrinogen Oxidase (Protox)IBA
05/2001 - 11/2000
1PorphyrinsIBA
02/2009
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2001
1NeuropilinsIBA
10/2001
1Vascular Endothelial Growth Factor DIBA
02/2001
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2001
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
02/2001
1Saline SolutionIBA
11/2000
1lazabemideIBA
11/2000
1Monoamine Oxidase (MAO)IBA
11/2000
1Selegiline (E250)FDA LinkGeneric
11/2000
1Ferrochelatase (Heme Synthetase)IBA
09/2000
1Sympathomimetics (Sympathomimetic Amines)IBA
01/2000

Therapy/Procedure

1Intravesical Administration
04/2001